A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
A class of diabetes medications may reduce the risk of colorectal cancer
- Post author:
- Post published:December 7, 2023
- Post category:uncategorized